ArticleCureus2026
Sarcopenia Risk Identified by Strength, Assistance With Walking, Rising From a Chair, Climbing Stairs, and Falls (SARC-F) in Patients With Cirrhosis: A Real-World Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSarcopenia is highly prevalent in patients with liver cirrhosis and is associated with increased morbidity, hospitalization, and mortality. However, routine screening is not consistently performed in clinical practice. The strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire is a simple tool that may facilitate early identification of sarcopenia risk.
methodsThis cross-sectional study included adult patients with cirrhosis attending a tertiary government hospital in Bahrain between January 1, 2024, and December 31, 2025. Sarcopenia risk was assessed using the SARC-F questionnaire, with a score ≥4 indicating high risk. Clinical and laboratory data were collected. Multivariable logistic regression was used to identify independent predictors of sarcopenia risk.
resultsA total of 362 patients were included (mean age 56.8 ± 11.9 years; 221 (61.0%) males). High sarcopenia risk (SARC-F ≥4) was identified in 129 patients (35.6%). Patients with high risk were older (60.2 vs 54.9 years, p < 0.001), had higher model for end-stage liver disease (MELD) scores (14.6 vs 11.2, p < 0.001), and more frequent ascites (75 (58.1%) vs 80 (34.5%), p < 0.001). They also had higher rates of hospitalization (55 (42.6%) vs 54 (23.3%), p < 0.001). On multivariable analysis, age (adjusted odds ratio (aOR): 1.05; 95% CI: 1.02-1.07), MELD score (aOR: 1.09; 95% CI: 1.04-1.14), and ascites (aOR: 1.87; 95% CI: 1.18-2.95) were independently associated with sarcopenia risk.
conclusionsSarcopenia risk appears to be common among patients with cirrhosis and is associated with markers of disease severity. The SARC-F questionnaire may serve as a simple screening tool to identify patients at higher risk in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.